Abstract
The recent epic2 publication (Pratt et al, 2007) provides evidence-based guidelines for the prevention of healthcare-associated infections. One of the new recommendations related to the prevention of central venous catheter (CVC) associated infection states that 2% chlorhexidine gluconate (CHG) in 70% isopropyl alcohol (IPA) should be used for cutaneous antisepsis prior to device insertion. This article reviews cutaneous antisepsis prior to intravascular catheter placement.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
2-Propanol / therapeutic use
-
Anti-Infective Agents, Local / therapeutic use*
-
Catheterization, Central Venous* / adverse effects
-
Chlorhexidine / analogs & derivatives
-
Chlorhexidine / therapeutic use
-
Clinical Trials as Topic
-
Cross Infection / epidemiology
-
Cross Infection / etiology
-
Cross Infection / prevention & control
-
England / epidemiology
-
Evidence-Based Medicine
-
Humans
-
Infection Control / methods*
-
Infection Control / standards
-
Povidone-Iodine / therapeutic use
-
Practice Guidelines as Topic
-
Sepsis / epidemiology
-
Sepsis / etiology
-
Sepsis / prevention & control
-
Skin Care / methods*
-
Skin Care / standards
Substances
-
Anti-Infective Agents, Local
-
Povidone-Iodine
-
chlorhexidine gluconate
-
2-Propanol
-
Chlorhexidine